AMX0114

· Amylyx Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMX0114, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis [Phase 1]